Less frequent delivery of medications which provide continuous exposure of medication
Formulation and device systems which are amenable to combination products
Effective and efficient oral delivery systems for biologics in Type 2 diabetes
Glucose-responsive delivery systems for insulin
Monthly, Quarterly, and Yearly administration providing continuous exposure of GLP-1 and other Type 2 diabetes drugs
Administration by a simple injection in the doctor’s office using a 27 guage needle and less than 1 ml injection volume
Insulin injection that is once per day or once per week and acts as a subcutaneous reservoir delivering insulin based on the glucose level
Patient administered product using a 29 to 31 guage needle and less than 0.5 ml injection volume
